We champion founders who take on the most important challenges in biology and health care with integrity and determination, providing them with the capital and resources to succeed.

Our investment thesis is focused on innovations across genomics + diagnostics, digital health, and synthetic biology. Our portfolio includes category-defining companies in AI and liquid biopsy-based technologies, gene editing, value-based care and cell therapies.

Our “founder-first” approach to investing is inspired by our own experience as founders and is rooted in humility, empathy and deep operational and scientific expertise.